Standout Papers

Management of glioblastom... 2020 2026 2022 2024 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Management of glioblastoma: State of the art and future directions
    2020 1.4k citations Aaron C. Tan, David M. Ashley et al. CA A Cancer Journal for Clinicians

Immediate Impact

1 from Science/Nature 56 hit
Sub-graph 1 of 22

Citing Papers

Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma
2025 Hit
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
2025 Hit
5 intermediate papers

Works of Michael D. Malinzak being referenced

Management of glioblastoma: State of the art and future directions
2020 Hit

Author Peers

Author Last Decade Papers Cites
Michael D. Malinzak 640 618 351 334 296 37 1.9k
David J. Pisapia 964 703 363 238 266 85 2.6k
Volker Senner 691 395 237 205 164 45 1.6k
Jason Heth 874 444 219 173 217 56 2.1k
Allen Waziri 511 874 258 451 156 51 2.2k
Stéphan Saïkali 696 765 372 269 71 59 1.9k
Peter McL. Black 535 681 255 228 205 23 1.7k
Akio Soeda 558 498 457 475 119 24 1.7k
Yoji Yamashita 618 831 239 299 250 64 1.8k
Thomas Mathivet 1524 336 275 324 197 43 3.1k
Tal Shahar 570 606 384 198 82 44 1.6k

All Works

Loading papers...

Rankless by CCL
2026